Literature DB >> 26142169

A long-term evaluation of cryoballoon ablation in 205 atrial fibrillation patients: a single center experience.

Alexander Bohó1,2, Silvia Mišíková3, Peter Spurný4, Erika Komanová4, Michal Kerekanič4,5, Marek Hudák4,5, Branislav Stančák6,7.   

Abstract

BACKGROUND: Atrial fibrillation is the most prevalent cardiac arrhythmia with significant healthcare impact with regards to treatment costs, morbidity, and mortality. Many of the focal electrical activities that initiate and sustain atrial fibrillation have been found to reside within or near the pulmonary veins. Consequently, pulmonary vein isolation by catheter ablation has emerged as an effective method to eliminate the focal triggers associated with atrial fibrillation.
METHODS: In this single-center study, 205 patients were ablated for atrial fibrillation using a cryoballoon catheter and followed-up long-term by retrospective chart examination to evaluate their post-procedural freedom from atrial fibrillation.
RESULTS: Patients were followed for up to 6 years with a cohort median of 3 years of post-ablation evaluation. Overall, at 12, 24, and 36 months post-ablation, 71, 49, and 31% of evaluated patients were free of atrial fibrillation, respectively. We found the type of atrial fibrillation (paroxysmal vs. persistent) as an independent predictor for arrhythmia recurrence (HR 1.97; 95% CI: 1.24-3.13, P  = 0.006). The cohort median atrial fibrillation-free survival time was 24 months (27 months for paroxysmal atrial fibrillation patients and 14 months for persistent atrial fibrillation patients). There were a total of 37 (18%) complications, 8 (3.9%) were categorized as major complications, all without permanent sequels. The most common complication was phrenic nerve palsy which occurred in 14 (6.8%) patients.
CONCLUSION: Long-term outcomes in this study suggest that the pulmonary vein isolation using the cryoballoon technique is relatively an effective method especially in the treatment of paroxysmal atrial fibrillation.

Entities:  

Keywords:  Atrial fibrillation; Catheter ablation; Complications; Cryoballoon; Efficacy

Mesh:

Year:  2015        PMID: 26142169     DOI: 10.1007/s00508-015-0816-5

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  28 in total

1.  Improved 1-year clinical success rate of pulmonary vein isolation with the second-generation cryoballoon in patients with paroxysmal atrial fibrillation.

Authors:  Alexander Fürnkranz; Stefano Bordignon; Daniela Dugo; Laura Perotta; Melanie Gunawardene; Britta Schulte-Hahn; Bernd Nowak; Boris Schmidt; Julian K R Chun
Journal:  J Cardiovasc Electrophysiol       Date:  2014-05-02

2.  A comprehensive evaluation of rhythm monitoring strategies for the detection of atrial fibrillation recurrence: insights from 647 continuously monitored patients and implications for monitoring after therapeutic interventions.

Authors:  Efstratios I Charitos; Ulrich Stierle; Paul D Ziegler; Malte Baldewig; Derek R Robinson; Hans-Hinrich Sievers; Thorsten Hanke
Journal:  Circulation       Date:  2012-07-23       Impact factor: 29.690

3.  Cryoballoon ablation of paroxysmal atrial fibrillation: 5-year outcome after single procedure and predictors of success.

Authors:  Thomas Neumann; Maciej Wójcik; Alexander Berkowitsch; Damir Erkapic; Sergey Zaltsberg; Harald Greiss; Dimitri Pajitnev; Stefan Lehinant; Jörn Schmitt; Christian W Hamm; Heinz F Pitschner; Malte Kuniss
Journal:  Europace       Date:  2013-02-17       Impact factor: 5.214

4.  Treating atrial fibrillation: pulmonary vein isolation with the cryoballoon technique.

Authors:  Nick Jackson; Malcolm Barlow; James Leitch; John Attia
Journal:  Heart Lung Circ       Date:  2012-05-02       Impact factor: 2.975

5.  Efficacy and safety of pulmonary veins isolation by cryoablation for the treatment of paroxysmal and persistent atrial fibrillation.

Authors:  Pascal Defaye; Adama Kane; Ali Chaib; Peggy Jacon
Journal:  Europace       Date:  2011-03-31       Impact factor: 5.214

6.  Increased incidence of esophageal thermal lesions using the second-generation 28-mm cryoballoon.

Authors:  Andreas Metzner; Andre Burchard; Peter Wohlmuth; Peter Rausch; Alexander Bardyszewski; Christina Gienapp; Roland Richard Tilz; Andreas Rillig; Shibu Mathew; Sebastian Deiss; Hisaki Makimoto; Feifan Ouyang; Karl-Heinz Kuck; Erik Wissner
Journal:  Circ Arrhythm Electrophysiol       Date:  2013-06-07

7.  Phrenic nerve paralysis during cryoballoon ablation for atrial fibrillation: a comparison between the first- and second-generation balloon.

Authors:  Ruben Casado-Arroyo; Gian-Battista Chierchia; Giulio Conte; Moisés Levinstein; Juan Sieira; Moises Rodriguez-Mañero; Giacomo di Giovanni; Yannis Baltogiannis; Kristel Wauters; Carlo de Asmundis; Andrea Sarkozy; Pedro Brugada
Journal:  Heart Rhythm       Date:  2013-07-24       Impact factor: 6.343

8.  Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial.

Authors:  Douglas L Packer; Robert C Kowal; Kevin R Wheelan; James M Irwin; Jean Champagne; Peter G Guerra; Marc Dubuc; Vivek Reddy; Linda Nelson; Richard G Holcomb; John W Lehmann; Jeremy N Ruskin
Journal:  J Am Coll Cardiol       Date:  2013-03-21       Impact factor: 24.094

9.  Incidence and predictors of left atrial thrombus prior to catheter ablation of atrial fibrillation.

Authors:  Daniel Scherr; Darshan Dalal; Karuna Chilukuri; Jun Dong; David Spragg; Charles A Henrikson; Saman Nazarian; Alan Cheng; Ronald D Berger; Theodore P Abraham; Hugh Calkins; Joseph E Marine
Journal:  J Cardiovasc Electrophysiol       Date:  2008-10-27

10.  Circumferential pulmonary vein isolation with the cryoballoon technique results from a prospective 3-center study.

Authors:  Thomas Neumann; Jürgen Vogt; Burghard Schumacher; Anja Dorszewski; Malte Kuniss; Hans Neuser; Klaus Kurzidim; Alexander Berkowitsch; Marcus Koller; Johannes Heintze; Ursula Scholz; Ulrike Wetzel; Michael A E Schneider; Dieter Horstkotte; Christian W Hamm; Heinz-Friedrich Pitschner
Journal:  J Am Coll Cardiol       Date:  2008-07-22       Impact factor: 24.094

View more
  2 in total

Review 1.  The Short and Long-Term Efficacy of Pulmonary Vein Isolation as a Sole Treatment Strategy for Paroxysmal Atrial Fibrillation: A Systematic Review and Meta-Analysis.

Authors:  Zsuzsanna Kis; Taulant Muka; Oscar H Franco; Wichor M Bramer; Lennart J De Vries; Attila Kardos; Tamas Szili-Torok
Journal:  Curr Cardiol Rev       Date:  2017

2.  Cryoballoon Ablation for Treatment of Atrial Fibrillation in a Chinese Population: Five-Year Outcomes and Predictors of Recurrence After a Single Procedure.

Authors:  Xiongbiao Chen; Yu Xia; Yuan Lin; Xiaofeng Li; Chun Wang; Yanjun Chen; Pihua Fang; Jun Liu
Journal:  Front Cardiovasc Med       Date:  2022-04-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.